Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/15/23 → 8/15/26 |
Funding
- Merck Sharp & Dohme LLC (Prot #MK-0472-001)
Prot #MK‐0472‐001: A Phase 1/1b Open‐label, Multicenter Clinical Study of MK‐0472 as Monotherapy and Combination Therapy in Participants with Advanced/Metastatic Solid Tumors
- Mahalingam, Devalingam (PD/PI)
Project: Research project